Skip to main content
OpenTrials
Completed

NCT Number: NCT00185887

Nitroglycerin Versus Terbutaline for Intrapartum Fetal Resuscitation

To compare nitroglycerin and terbutaline for intrapartum fetal heart rate resuscitation

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Fetal Distress Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Stanford University School of Medicine

Stanford, California, 94305, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

:

  • nonreassuring fetal heart rate tracing Exclusion Criteria:- maternal cardiac disease, placental abruption, intrauterine growth restriction, prior cesarean section

Treatment and study plan

Terbutaline

Drug

Terbutaline 250 micrograms intravenously for intrapartum fetal resuscitation. Nitroglycerine 400 micrograms intravenously for intrapartum fetal resuscitation.

Primary outcomes

  1. resolution of abnormal fetal heart tracing

    Time frame: Administration of study medication to resolution of abnormal fetal heart tracing or operative delivery.

Secondary outcomes

  1. cesarean section rate

    Time frame: Data analysis

  2. operative vaginal delivery rate

    Time frame: Data analysis

  3. neonatal outcomes

    Time frame: time of delivery to time of discharge

Sponsors and collaborators

Lead sponsor

Stanford University

Other

Registry information

Important dates

Study start
2003
Primary completion
2006
Study completion
2007
First posted
Sep 16, 2005
Registry last updated
Mar 8, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.